Version 5.4
Bos taurus Gene: USP32
Summary
InnateDB Gene IDBG-630184.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol USP32
Gene Name Ubiquitin carboxyl-terminal hydrolase
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000020089
Encoded Proteins
IDBP-681676
ubiquitin specific peptidase 32
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000170832:
Gene Information
Type Protein coding
Genomic Location Chromosome 19:12986898-13084710
Strand Forward strand
Band
Transcripts
ENSBTAT00000026766 ENSBTAP00000026766
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 21 interaction(s) predicted by orthology.
Predicted by orthology
Total 21 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004843 ubiquitin-specific protease activity
GO:0005509 calcium ion binding
GO:0008233 peptidase activity
GO:0008234 cysteine-type peptidase activity
GO:0016787 hydrolase activity
GO:0036459 ubiquitinyl hydrolase activity
Biological Process
GO:0006508 proteolysis
GO:0006511 ubiquitin-dependent protein catabolic process
Cellular Component
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000170832
View Gene Order
ENSMUSG00000000804
View Gene Order
Cross-References
SwissProt
TrEMBL F1N3S5
UniProt Splice Variant
Entrez Gene
UniGene Bt.110642
RefSeq
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02048411 DAAA02048412 DAAA02048413 DAAA02048414
GenPept
RNA Seq Atlas

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca